Interestingly, both Type I and Type II IFN contribute to the early induction of IFN-stimulated genes (ISGs); however, Type II IFN and STAT1 are dispensable for murine arthritis development, whereas blockage of Type I IFN signaling leads to reduced joint pathology [23,27–29]. This evidence concerns the gene IFNA1 and arthritic joint disease.